Oxford Pharmascience Group (OXP)

 

OXP Share PerformanceMore

52 week high3.6065 08/02/17
52 week low1.3510 29/06/17
52 week change -1.6500 (-50.77%)
4 week volume10,703,826 25/06/17

Media for (OXP)

Presenter: Marcelo Bravo
25/01/2017
Presenter: Marcelo Bravo
13/09/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

All resolutions passed at AGM of Oxford Pharmascience

Oxford Pharmascience Group has confirmed that all resolutions were passed by shareholders at today's Annual General M...

Result of AGM

RNS Number: 4736I Oxford Pharmascience Group PLC 19 June 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Result of AGM Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, is pleased to announce that at its Annual Ge...

Further Update re: OXPzero Ibuprofen Programmes

RNS Number: 5108H Oxford Pharmascience Group PLC 08 June 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the " Company ") Further Update R egarding OXPzero TM Ibuprofen Programmes Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easie...

Update regarding OXPzeroTM Ibuprofen Programmes

RNS Number: 5321E Oxford Pharmascience Group PLC 09 May 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Update regarding OXPzeroTM Ibuprofen Programmes Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, pr...

Miners drag on FTSE as commodity prices fall

Weaker commodity prices hit miners with Anglo American (AAL), Antofagasta (ANTO) and BHP Billiton (BLT) falling b...

Second Price Monitoring Extn

RNS Number: 1522B Oxford Pharmascience Group PLC 31 March 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-d...

FTSE falls on miners, financials as Old Mutual suffers

London shares were a little lower in early deals with heavyweight miners providing decisive ballast, but Old Mutual took t...

Price Monitoring Extension

RNS Number: 1516B Oxford Pharmascience Group PLC 31 March 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before ...

Fundamental DataMore

EPS-0.11
Dividend yield0 %

Latest discussion posts More

  • Re: At least 18 months

    That seems logical, I will hold on in the HOPE it passes 2p and take a small profit, if not, leave for 2 or 3 years and most probably have this same conversation again.
    3-Apr-2017
    Hyperproject
  • Re: At least 18 months

    I've bailed after a big hit! The way I read it, they have no product. If they want to release it as planned then they need more trials which could cost millions and also, ...
    2-Apr-2017
    high blood pressure1
  • At least 18 months

    I have committed today at 1.7p, my first investment ever in anything outside the FT250. From my understanding of this sector, I don't expect much movement either up or down for ...
    31-Mar-2017
    Hyperproject

Users' HoldingsMore

Users who hold Oxford Pharmascience Group also hold..
LLOYDS GRP.17%
SIRIUS MINERALS17%
ID:ISIN:VGG9828A119413%
GLAXOSMITHKLINE11%
OXFORD BIOMED.11%

Codes & Symbols

ISINGB00B3LXPB43
SymbolsOXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP